Literature DB >> 21249471

Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia.

Marco Falcone1, Salvatore Corrao, Mario Venditti, Pietro Serra, Giuseppe Licata.   

Abstract

The objective was to compare three score systems, pneumonia severity index (PSI), the Confusion-Urea-Respiratory Rate-Blood pressure-65 (CURB-65), and severe community-acquired pneumonia (SCAP), for prediction of the outcomes in a cohort of patients with community-acquired (CAP) and healthcare-associated pneumonia (HCAP). Large multi-center, prospective, observational study was conducted in 55 hospitals. HCAP patients were included in the high classes of CURB-65, PSI and SCAP scores have a mortality rate higher than that of CAP patients. HCAP patients included in the low class of the three severity rules have a significantly higher incidence of adverse events, including development of septic shock, transfer into an ICU, and death (p < 0.01). At multivariate Cox regression analysis, inclusion in the severe classes of PSI, CURB-65, or SCAP scores and receipt of an empirical therapy not adherent to international guidelines prove to be risk factors independently associated with poor outcome. PSI, CURB-65, and SCAP score have a good performance in patients with CAP but are less useful in patients with HCAP, especially in patients classified in the low-risk classes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21249471     DOI: 10.1007/s11739-011-0521-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  12 in total

1.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Role of multidrug-resistant pathogens in health-care-associated pneumonia.

Authors:  Marco Falcone; Mario Venditti; Salvatore Corrao; Pietro Serra
Journal:  Lancet Infect Dis       Date:  2011-01       Impact factor: 25.071

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

4.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

5.  Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

Authors:  Pedro P España; Alberto Capelastegui; Inmaculada Gorordo; Cristobal Esteban; Mikel Oribe; Miguel Ortega; Amaia Bilbao; José M Quintana
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

6.  Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

Authors:  Mario Venditti; Marco Falcone; Salvatore Corrao; Giuseppe Licata; Pietro Serra
Journal:  Ann Intern Med       Date:  2009-01-06       Impact factor: 25.391

7.  Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital.

Authors:  Yuichiro Shindo; Shinji Sato; Eiichi Maruyama; Takamasa Ohashi; Masahiro Ogawa; Naozumi Hashimoto; Kazuyoshi Imaizumi; Tosiya Sato; Yoshinori Hasegawa
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

8.  Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Authors:  Scott T Micek; Katherine E Kollef; Richard M Reichley; Nareg Roubinian; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

9.  Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience.

Authors:  Marya D Zilberberg; Andrew F Shorr; Scott T Micek; Samir H Mody; Marin H Kollef
Journal:  Chest       Date:  2008-07-18       Impact factor: 9.410

10.  Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.

Authors:  Andrew F Shorr; Marya D Zilberberg; Scott T Micek; Marin H Kollef
Journal:  Arch Intern Med       Date:  2008-11-10
View more
  21 in total

1.  A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Yuichiro Shindo; Alessio Farcomeni; Filippo Pieralli; Roberto Cangemi; Jinliang Liu; Jingyan Xia; Junya Okumura; Masahiro Sano; Christopher Jones; Vieri Vannucchi; Massimo Mancone; Scott Micek; Feng Xu; Francesco Violi; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Early identification of severe community-onset pneumonia in "frail elderly patient".

Authors:  Alessandro Russo; Marco Falcone; Mario Venditti
Journal:  Intern Emerg Med       Date:  2013-11-28       Impact factor: 3.397

3.  Emerging problems regarding severity assessment and treatment strategies for patients with pneumonia: controversies surrounding the HCAP concept.

Authors:  Yuichiro Shindo; Yoshinori Hasegawa
Journal:  Intern Emerg Med       Date:  2011-05-18       Impact factor: 3.397

4.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

5.  CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.

Authors:  Q Guo; H-Y Li; Y-P Zhou; M Li; X-K Chen; H Liu; H-L Peng; H-Q Yu; X Chen; N Liu; L-H Liang; Q-Z Zhao; M Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-18       Impact factor: 3.267

6.  Performance status and in-hospital mortality of elderly patients with community acquired pneumonia.

Authors:  Filippo Pieralli; Vieri Vannucchi; Giulia De Marzi; Antonio Mancini; Francesca Bacci; Ombretta Para; Carlo Nozzoli; Marco Falcone
Journal:  Intern Emerg Med       Date:  2018-03-09       Impact factor: 3.397

7.  Guideline-based antibiotics and mortality in healthcare-associated pneumonia.

Authors:  Karl J Madaras-Kelly; Richard E Remington; Kevin L Sloan; Vincent S Fan
Journal:  J Gen Intern Med       Date:  2012-03-07       Impact factor: 5.128

8.  Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.

Authors:  Marco Falcone; Salvatore Corrao; Giuseppe Licata; Pietro Serra; Mario Venditti
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

Review 9.  Pneumonia in frail older patients: an up to date.

Authors:  Marco Falcone; Francesco Blasi; Francesco Menichetti; Federico Pea; Francesco Violi
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

10.  B-type natriuretic peptide in predicting the severity of community-acquired pneumonia.

Authors:  Jing Li; Huan Ye; Li Zhao
Journal:  World J Emerg Med       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.